Results 271 to 280 of about 81,579 (355)

Correction: Sławek et al. Case Series and Literature Review on Botulinum Toxin Efficacy in Axial Extensor Truncal Dystonia. <i>Toxins</i> 2025, <i>17</i>, 375. [PDF]

Toxins (Basel)
Sławek J, Łobińska IA, Schinwelski M, Kopcewicz-Wiśniewska J, Castagna A.   +4 more
europepmc   +1 more source

Interplay Between Sex and Cytosine‐Adenine‐Guanine‐Age Product Score in Huntington's Disease: Clinical and Neuroimaging Perspectives

Movement Disorders, EarlyView.
Abstract Background Huntington's disease (HD) is a progressive neurodegenerative disorder caused by a cytosine‐adenine‐guanine (CAG) repeat expansion in the huntingtin gene. The disease exhibits sex‐related differences in symptomatology and disease progression, but the effect on brain structural biomarkers and the interaction between sex and CAG‐age ...
Jingwen Yao, Grayson Feng, Guowen Shao, Zexi Wang, Adys Mendizabal, Donatello Telesca, Kaiying Fang, Lola Ibragimova, Juwairia Shoaib, Melanie A. Morrison, Janine M. Lupo   +10 more
wiley   +1 more source

Functional Neurological Disorder: A Case of Twisted Toes and Dystonia. [PDF]

Cureus
McPherson RJ, Santos-Rivera JR, Fonarov I.   +2 more
europepmc   +1 more source

Meningitis with Dystonia

Journal of the Royal Society of Medicine, 1996
openaire   +4 more sources

Dystonia and Ataxia Associated with Brain Iron Accumulation: Expanding the Phenotype of NPTX1‐Spinocerebellar Ataxia 50

Movement Disorders, EarlyView.
Gianmarco Dalla Zanna, Alessandra Tessa, Salvatore Rossi, Antonio Funcis, Francesca Brambati, Anna Modoni, Rosellina Russo, Paolo Calabresi, Filippo Maria Santorelli, Gabriella Silvestri   +9 more
wiley   +1 more source

Longitudinal Blood‐Biomarker‐Based Assessment of Brain Injury in Patients Undergoing Deep Brain Stimulation and Magnetic Resonance–Guided Focused Ultrasound

Movement Disorders, EarlyView.
Abstract Background Deep brain stimulation (DBS) and magnetic resonance–guided focused ultrasound (MRgFUS) are associated with neuroaxonal damage and astroglial activation; yet their extent and timing remain unclear despite clinical relevance for monitoring and outcome assessment.
Justina Dargvainiene, Ann‐Kristin Helmers, Juliana Naumann, Carl Alexander Gless, Bettina Möller, Julius Welzel, Frank Leypoldt, Johannes Hensler, Ina Tesseur, Klaus‐Peter Wandinger, Günther Deuschl, Daniela Berg, Steffen Paschen   +12 more
wiley   +1 more source

Combined molecular characterization and dopa-responsive treatment in two patients with NR4A2-associated intellectual developmental disorder. [PDF]

Front Genet
Liang N, Li T, Deng Y.
europepmc   +1 more source

Integrating Long‐Read Nanopore Sequencing for Precision Resolution of Genomic Variants in Dystonia

Movement Disorders, EarlyView.
Abstract Background Although many individuals with dystonia present with features indicative of single‐gene etiologies, obtaining definitive genetic diagnoses can be challenging. Objective We assessed the value of nanopore‐based long‐read sequencing (LRS) in achieving molecular clarification of dystonic syndromes.
Ugo Sorrentino, Martin Pavlov, Nazanin Mirza‐Schreiber, Melanie Brugger, Theresa Brunet, Eugenia Tsoma, Alice Saparov, Ivana Dzinovic, Philip Harrer, Antonia M. Stehr, Matias Wagner, Erik Tilch, Barbara Wallacher, Shiraz Alhasan, Anne Koy, Alessio Di Fonzo, Miriam Kolnikova, Katarina Kusikova, Petra Havrankova, Raushana Tautanova, Sandy Lösecke, Sebastian Eck, Sylvia Boesch, Jan Necpal, Matej Skorvanek, Robert Jech, Holger Prokisch, Juliane Winkelmann, Konrad Oexle, Elisabeth Graf, Michael Zech   +30 more
wiley   +1 more source

Pediatric Genetic Dystonias: Current Diagnostic Approaches and Treatment Options. [PDF]

Life (Basel)
Ceraolo G, Spoto G, Consoli C, Modafferi E, Di Rosa G, Nicotera AG.   +5 more
europepmc   +1 more source

Rare but Relevant? Assessing Variants in Dystonia‐Linked Genes in Parkinson's Disease

Movement Disorders, EarlyView.
Abstract Background Dystonia and Parkinson's disease (PD) exhibit clinical and genetic overlap, but the relevance of dystonia gene variants in PD remains unclear. Objective The aim was to assess the frequency of dystonia‐linked pathogenic variants in PD.
Lara M. Lange, Zih‐Hua Fang, Laurel Screven, Ai Huey Tan, Roy N. Alcalay, Rim Amouri, Roberta Bovenzi, Matilda Fenn, Joshua L.I. Frost, Joseph Jankovic, Simona Jasaityte, Zane Jaunmuktane, Beomseok Jeon, Ignacio Juan Keller Sarmiento, Rejko Krüger, Gregor Kuhlenbäumer, Chin‐Hsien Lin, Lukas Pavelka, Maria Teresa Periñan, Samia Ben Sassi, Tommaso Schirinzi, Jung Hwan Shin, Joshua M. Shulman, Yi Wen Tay, Ryan Uitti, Tom Warner, Zbigniew K. Wszolek, Lesley Wu, Ruey‐Meei Wu, Kirsten E. Zeuner, Cornelis Blauwendraat, Andrew Singleton, Niccolò E. Mencacci, Huw R. Morris, Shen‐Yang Lim, Katja Lohmann, Christine Klein, the Global Parkinson's Genetics Program (GP2)   +37 more
wiley   +1 more source